These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 23978641)
1. Distinct features of distant metastasis and lymph node stage in lung adenocarcinoma patients with epidermal growth factor receptor gene mutations. Enomoto Y; Takada K; Hagiwara E; Kojima E Respir Investig; 2013 Sep; 51(3):153-7. PubMed ID: 23978641 [TBL] [Abstract][Full Text] [Related]
2. Advanced adenocarcinoma of the lung: comparison of CT characteristics of patients with anaplastic lymphoma kinase gene rearrangement and those with epidermal growth factor receptor mutation. Choi CM; Kim MY; Hwang HJ; Lee JB; Kim WS Radiology; 2015 Apr; 275(1):272-9. PubMed ID: 25575117 [TBL] [Abstract][Full Text] [Related]
3. Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT. Choi H; Paeng JC; Kim DW; Lee JK; Park CM; Kang KW; Chung JK; Lee DS Lung Cancer; 2013 Mar; 79(3):242-7. PubMed ID: 23261227 [TBL] [Abstract][Full Text] [Related]
4. Relationship between EGFR gene mutation and local metastasis of resectable lung adenocarcinoma. Nie Y; Gao W; Li N; Chen W; Wang H; Li C; Zhang H; Han P; Zhang Y; Lv X; Xu X; Liu H World J Surg Oncol; 2017 Mar; 15(1):55. PubMed ID: 28253871 [TBL] [Abstract][Full Text] [Related]
5. Radiotherapy in lung adenocarcinoma with brain metastases: effects of activating epidermal growth factor receptor mutations on clinical response. Gow CH; Chien CR; Chang YL; Chiu YH; Kuo SH; Shih JY; Chang YC; Yu CJ; Yang CH; Yang PC Clin Cancer Res; 2008 Jan; 14(1):162-8. PubMed ID: 18172267 [TBL] [Abstract][Full Text] [Related]
6. EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases. Schmid K; Oehl N; Wrba F; Pirker R; Pirker C; Filipits M Clin Cancer Res; 2009 Jul; 15(14):4554-60. PubMed ID: 19584155 [TBL] [Abstract][Full Text] [Related]
7. Tumor burden is predictive of survival in patients with non-small-cell lung cancer and with activating epidermal growth factor receptor mutations who receive gefitinib. Park JH; Kim TM; Keam B; Jeon YK; Lee SH; Kim DW; Chung DH; Kim YT; Kim YW; Heo DS Clin Lung Cancer; 2013 Jul; 14(4):383-9. PubMed ID: 23313171 [TBL] [Abstract][Full Text] [Related]
8. EGFR mutation and brain metastasis in pulmonary adenocarcinomas. Shin DY; Na II; Kim CH; Park S; Baek H; Yang SH J Thorac Oncol; 2014 Feb; 9(2):195-9. PubMed ID: 24419416 [TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor gene mutation defines distinct subsets among small adenocarcinomas of the lung. Haneda H; Sasaki H; Shimizu S; Endo K; Suzuki E; Yukiue H; Kobayashi Y; Yano M; Fujii Y Lung Cancer; 2006 Apr; 52(1):47-52. PubMed ID: 16503085 [TBL] [Abstract][Full Text] [Related]
10. Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung. Kim YT; Kim TY; Lee DS; Park SJ; Park JY; Seo SJ; Choi HS; Kang HJ; Hahn S; Kang CH; Sung SW; Kim JH Lung Cancer; 2008 Jan; 59(1):111-8. PubMed ID: 17904685 [TBL] [Abstract][Full Text] [Related]
12. Cytomorphological identification of advanced pulmonary adenocarcinoma harboring KRAS mutation in lymph node fine-needle aspiration specimens: Comparative investigation of adenocarcinoma with KRAS and EGFR mutations. Song DH; Lee B; Shin Y; Choi IH; Ha SY; Lee JJ; Hong ME; Choi YL; Han J; Um SW Diagn Cytopathol; 2015 Jul; 43(7):539-44. PubMed ID: 25427298 [TBL] [Abstract][Full Text] [Related]